CRIS

NASD Curis, Inc.
Oct 16, 2026 · 11:05 AM ET DELAYED Market Open

$0.3793 ↓ -0.1287 (-25.33%) Trading Down from the previous close of $0.5080, $0.0740 below the day’s high of $0.4533

YTD change
-98.08%
vs 20-day SMA
-51.96%
vs 200-day SMA
-96.22%

Price ranges

Previous day
$0.4650 $0.6086
open $0.5918 close $0.5080
-$0.0838 (-14.16%)
Today
$0.3250 $0.4533
open $0.4467 now $0.3793
-$0.0674 (-15.09%)
Past week
$0.4650 $0.7200
from $0.7094 now $0.3793
-$0.3301 (-46.53%)
Past month
$0.4650 $1.1280
from $1.0900 now $0.3793
-$0.7107 (-65.20%)
This year
$0.1806 $19.7420
from $19.7420 now $0.3793
-$19.3627 (-98.08%)

Price & Performance

-0.08 (-14.06%) / 6M

$-0.2529$1.96$4.18$6.40Apr 16Jul 17Oct 15

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 100.0% away from all-time highs of $7,440.0000
  • CRIS is down 98% since the beginning of the year
  • CRIS is down 99% over the past 12 months
  • CRIS is down 65% over the past 1 month
  • 3% of all CRIS investors are betting against CRIS

CRIS reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -67.4%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-4.02
Earnings momentum -50.7% Quarterly EPS growth
Quarterly change -50.7%

Valuation

P/E ratio N/A
Enterprise value $-3487960.0
Beta 5.01

Balance sheet & scale

IncomeN/A
Revenue$4.3M
Cash$5.6M
Debt$1.0K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $2.2M

Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.

Competitor comparison

TickerCompany PriceChange
CSLLY CSL Limited Sponsored ADR $32.60 +1.02%
ARGX argenx SE Sponsored ADR $846.27 +3.42%
ONC BeOne Medicines Ltd. Sponsored ADR $374.08 +6.43%
WXXWY WuXi Biologics (Cayman) Inc. Unsponsored ADR $12.50 +1.21%
INCY Incyte Corporation $113.27 +1.52%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.